Literature DB >> 2890380

Interaction of phosphonates related to glutathione with the rat kidney gamma-glutamylcysteine synthetase.

M Marche1, M J Basurko, A Cassaigne.   

Abstract

Various phosphonic and sulfonic glutamate analogues as well as phosphonopeptides related to glutathione were studied for their interaction with rat kidney gamma-glutamylcysteine synthetase activity. We found, in all cases, that the presence of a phosphonic group increases the affinity for the enzyme. Among the tripeptides tested, the phosphonic analogue of ophthalmic acid (gamma Glu-Abu-Gly-P) is the most potent inhibitor. The glutamate and cysteine sites of the enzyme seem to be involved in the binding of this compound, since either substrate protects against inhibition. The types of inhibition with respect to the different substrates show dissimilar behaviors of the tripeptides, in spite of their structural analogy. Investigations relative to the role of the divalent ion Mg2+ provided evidence that the actual inhibitors are Mg2+-tripeptide complexes for the phosphonic compounds, whereas chelation with a metal ion is not required for inhibition by glutathione.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890380     DOI: 10.1016/0300-9084(87)90083-6

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Cancer incidence among Finnish people with type 2 diabetes during 1989-2014.

Authors:  Katri Saarela; Jaakko Tuomilehto; Reijo Sund; Ilmo Keskimäki; Sirpa Hartikainen; Eero Pukkala
Journal:  Eur J Epidemiol       Date:  2018-09-04       Impact factor: 8.082

2.  Causal effects of gallstone disease on risk of gastrointestinal cancer in Chinese.

Authors:  Yuanjie Pang; Jun Lv; Christiana Kartsonaki; Yu Guo; Canqing Yu; Yiping Chen; Ling Yang; Zheng Bian; Iona Y Millwood; Robin G Walters; Xiaojun Li; Ju Zou; Michael V Holmes; Junshi Chen; Zhengming Chen; Liming Li
Journal:  Br J Cancer       Date:  2021-03-26       Impact factor: 7.640

3.  Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation.

Authors:  Yu Lei; Shuling Zhou; Qiaoling Hu; Xueling Chen; Jiang Gu
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.